Center-Authored Papers

Filters: Author is Wang, Yinghui  [Clear All Filters]
2017
Prince MH, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL et al..  2017.  Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.. Lancet (London, England). Abstract
2015
Forero-Torres A, Holkova B, Goldschmidt J, Chen R, Olsen G, Boccia RV, Bordoni RE, Friedberg JW, Sharman JP, Palanca-Wessels MC et al..  2015.  Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older.. Blood. 126(26):2798-2804. Abstract
2014
Hubers JA, van der Drift MA, Prinsen CFM, Witte BI, Wang Y, Shivapurkar N, Bolijn AS, Hol BEA, Feng Z, Dekhuijzen RPN et al..  2014.  Methylation analysis in spontaneous sputum for lung cancer diagnosis.. Lung cancer (Amsterdam, Netherlands). Abstract
2011
Loo LWM, Wang Y, Flynn EM, Lund MJ, Bowles EAJ, Buist DSM, Liff JM, Flagg EW, Coates RJ, Eley WJ et al..  2011.  Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women.. Breast cancer research and treatment. 127(1):297-308. Abstract
2010
Wernli KJ, Newcomb PA, Wang Y, Makar KW, Shadman M, Chia VM, Burnett-Hartman A, Wurscher MA, Zheng Y, Mandelson MT.  2010.  Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps.. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. 20(4):305-9. Abstract
2009
Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, Reddy RK, Harnois D, Llovet JM, Normolle D et al..  2009.  Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.. Gastroenterology. 137(1):110-8. Abstract
Wernli KJ, Wang Y, Zheng Y, Potter JD, Newcomb PA.  2009.  The relationship between gravidity and parity and colorectal cancer risk.. Journal of women's health (2002). 18(7):995-1001. Abstract
Schenk JM, Riboli E, Chatterjee N, Leitzmann MF, Ahn J, Albanes D, Reding DJ, Wang Y, Friesen MD, Hayes RB et al..  2009.  Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(4):1227-31. Abstract
2008
Peters U, Chatterjee N, Hayes RB, Schoen RE, Wang Y, Chanock SJ, Foster CB.  2008.  Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(5):1144-54. Abstract
Sokoll LJ, Wang Y, Feng Z, Kagan J, Partin AW, Sanda MG, Thompson IM, Chan DW.  2008.  [-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation study.. The Journal of urology. 180(2):539-43;discussion543. Abstract